Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration

Background: Neurodegenerative diseases are incurable disorders caused by progressive neuronal cell death. Retinitis pigmentosa (RP) is a blinding neurodegenerative disease that results in photoreceptor death and progresses to the loss of the entire retinal network. We previously found that proteomic...

Full description

Bibliographic Details
Main Authors: Katherine J. Wert, Gabriel Velez, Vijaya L. Kanchustambham, Vishnu Shankar, Lucy P. Evans, Jesse D. Sengillo, Richard N. Zare, Alexander G. Bassuk, Stephen H. Tsang, Vinit B. Mahajan
Format: Article
Language:English
Published: Elsevier 2020-02-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396420300116
id doaj-9faaee8086dc409cadd8ba21adb03d1e
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Katherine J. Wert
Gabriel Velez
Vijaya L. Kanchustambham
Vishnu Shankar
Lucy P. Evans
Jesse D. Sengillo
Richard N. Zare
Alexander G. Bassuk
Stephen H. Tsang
Vinit B. Mahajan
spellingShingle Katherine J. Wert
Gabriel Velez
Vijaya L. Kanchustambham
Vishnu Shankar
Lucy P. Evans
Jesse D. Sengillo
Richard N. Zare
Alexander G. Bassuk
Stephen H. Tsang
Vinit B. Mahajan
Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration
EBioMedicine
author_facet Katherine J. Wert
Gabriel Velez
Vijaya L. Kanchustambham
Vishnu Shankar
Lucy P. Evans
Jesse D. Sengillo
Richard N. Zare
Alexander G. Bassuk
Stephen H. Tsang
Vinit B. Mahajan
author_sort Katherine J. Wert
title Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration
title_short Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration
title_full Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration
title_fullStr Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration
title_full_unstemmed Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration
title_sort metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegeneration
publisher Elsevier
series EBioMedicine
issn 2352-3964
publishDate 2020-02-01
description Background: Neurodegenerative diseases are incurable disorders caused by progressive neuronal cell death. Retinitis pigmentosa (RP) is a blinding neurodegenerative disease that results in photoreceptor death and progresses to the loss of the entire retinal network. We previously found that proteomic analysis of the adjacent vitreous served as way to indirectly biopsy the retina and identify changes in the retinal proteome. Methods: We analyzed protein expression in liquid vitreous biopsies from autosomal recessive (ar)RP patients with PDE6A mutations and arRP mice with Pde6ɑ mutations. Proteomic analysis of retina and vitreous samples identified molecular pathways affected at the onset of photoreceptor death. Based on affected molecular pathways, arRP mice were treated with a ketogenic diet or metabolites involved in fatty-acid synthesis, oxidative phosphorylation, and the tricarboxylic acid (TCA) cycle. Findings: Dietary supplementation of a single metabolite, ɑ-ketoglutarate, increased docosahexaeonic acid levels, provided neuroprotection, and enhanced visual function in arRP mice. A ketogenic diet delayed photoreceptor cell loss, while vitamin B supplementation had a limited effect. Finally, desorption electrospray ionization mass spectrometry imaging (DESI-MSI) on ɑ-ketoglutarate-treated mice revealed restoration of metabolites that correlated with our proteomic findings: uridine, dihydrouridine, and thymidine (pyrimidine and purine metabolism), glutamine and glutamate (glutamine/glutamate conversion), and succinic and aconitic acid (TCA cycle). Interpretation: This study demonstrates that replenishing TCA cycle metabolites via oral supplementation prolongs retinal function and provides a neuroprotective effect on the photoreceptor cells and inner retinal network. Funding: NIH grants [R01EY026682, R01EY024665, R01EY025225, R01EY024698, R21AG050437, P30EY026877, 5P30EY019007, R01EY018213, F30EYE027986, T32GM007337, 5P30CA013696], NSF grant CHE-1734082. Keywords: Metabolomics, Metabolite supplementation, TCA cycle, Ketogenic diet, ɑ-ketoglutarate, Desorption electrospray ionization mass spectrometry
url http://www.sciencedirect.com/science/article/pii/S2352396420300116
work_keys_str_mv AT katherinejwert metabolitetherapyguidedbyliquidbiopsyproteomicsdelaysretinalneurodegeneration
AT gabrielvelez metabolitetherapyguidedbyliquidbiopsyproteomicsdelaysretinalneurodegeneration
AT vijayalkanchustambham metabolitetherapyguidedbyliquidbiopsyproteomicsdelaysretinalneurodegeneration
AT vishnushankar metabolitetherapyguidedbyliquidbiopsyproteomicsdelaysretinalneurodegeneration
AT lucypevans metabolitetherapyguidedbyliquidbiopsyproteomicsdelaysretinalneurodegeneration
AT jessedsengillo metabolitetherapyguidedbyliquidbiopsyproteomicsdelaysretinalneurodegeneration
AT richardnzare metabolitetherapyguidedbyliquidbiopsyproteomicsdelaysretinalneurodegeneration
AT alexandergbassuk metabolitetherapyguidedbyliquidbiopsyproteomicsdelaysretinalneurodegeneration
AT stephenhtsang metabolitetherapyguidedbyliquidbiopsyproteomicsdelaysretinalneurodegeneration
AT vinitbmahajan metabolitetherapyguidedbyliquidbiopsyproteomicsdelaysretinalneurodegeneration
_version_ 1725077489964810240
spelling doaj-9faaee8086dc409cadd8ba21adb03d1e2020-11-25T01:33:24ZengElsevierEBioMedicine2352-39642020-02-0152Metabolite therapy guided by liquid biopsy proteomics delays retinal neurodegenerationKatherine J. Wert0Gabriel Velez1Vijaya L. Kanchustambham2Vishnu Shankar3Lucy P. Evans4Jesse D. Sengillo5Richard N. Zare6Alexander G. Bassuk7Stephen H. Tsang8Vinit B. Mahajan9Omics Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA 94304, United StatesOmics Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA 94304, United States; Medical Scientist Training Program, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, United StatesDepartment of Chemistry, Stanford University, Stanford, CA 94305, United StatesDepartment of Chemistry, Stanford University, Stanford, CA 94305, United StatesDepartments of Pediatrics and Neurology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, United StatesBascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL 33136, United StatesDepartment of Chemistry, Stanford University, Stanford, CA 94305, United StatesDepartments of Pediatrics and Neurology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, United StatesEdward S. Harkness Eye Institute, New York-Presbyterian Hospital, New York, NY 10032, United States; Jonas Children's Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, Department of Ophthalmology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, United States; Department of Pathology & Cell Biology, Stem Cell Initiative (CSCI), Institute of Human Nutrition, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, United StatesOmics Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA 94304, United States; Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, United States; Corresponding author at: Omics Laboratory, Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA 94304, United States.Background: Neurodegenerative diseases are incurable disorders caused by progressive neuronal cell death. Retinitis pigmentosa (RP) is a blinding neurodegenerative disease that results in photoreceptor death and progresses to the loss of the entire retinal network. We previously found that proteomic analysis of the adjacent vitreous served as way to indirectly biopsy the retina and identify changes in the retinal proteome. Methods: We analyzed protein expression in liquid vitreous biopsies from autosomal recessive (ar)RP patients with PDE6A mutations and arRP mice with Pde6ɑ mutations. Proteomic analysis of retina and vitreous samples identified molecular pathways affected at the onset of photoreceptor death. Based on affected molecular pathways, arRP mice were treated with a ketogenic diet or metabolites involved in fatty-acid synthesis, oxidative phosphorylation, and the tricarboxylic acid (TCA) cycle. Findings: Dietary supplementation of a single metabolite, ɑ-ketoglutarate, increased docosahexaeonic acid levels, provided neuroprotection, and enhanced visual function in arRP mice. A ketogenic diet delayed photoreceptor cell loss, while vitamin B supplementation had a limited effect. Finally, desorption electrospray ionization mass spectrometry imaging (DESI-MSI) on ɑ-ketoglutarate-treated mice revealed restoration of metabolites that correlated with our proteomic findings: uridine, dihydrouridine, and thymidine (pyrimidine and purine metabolism), glutamine and glutamate (glutamine/glutamate conversion), and succinic and aconitic acid (TCA cycle). Interpretation: This study demonstrates that replenishing TCA cycle metabolites via oral supplementation prolongs retinal function and provides a neuroprotective effect on the photoreceptor cells and inner retinal network. Funding: NIH grants [R01EY026682, R01EY024665, R01EY025225, R01EY024698, R21AG050437, P30EY026877, 5P30EY019007, R01EY018213, F30EYE027986, T32GM007337, 5P30CA013696], NSF grant CHE-1734082. Keywords: Metabolomics, Metabolite supplementation, TCA cycle, Ketogenic diet, ɑ-ketoglutarate, Desorption electrospray ionization mass spectrometryhttp://www.sciencedirect.com/science/article/pii/S2352396420300116